Position in LNSR
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$5,107
-$6,115 QoQ
Shares Held
857
-11.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNSR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $4,885,734,237 across 80 Medical Devices names. LNSR ranks #74 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
12,285,529 | $1,261,355,261 | |
| 2 | MDT |
Medtronic plc
|
10,316,815 | $893,952,018 | |
| 3 | SYK |
Stryker Corp
|
2,374,415 | $780,209,023 | |
| 4 | BSX |
Boston Scientific Corp
|
10,600,766 | $665,198,065 | |
| 5 | EW |
Edwards Lifesciences Corp
|
4,449,554 | $356,320,283 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
2,893,076 | $205,929,147 | |
| 7 | STE |
STERIS plc
|
764,436 | $169,039,731 | |
| 8 | DXCM |
Dexcom Inc
|
2,609,354 | $163,867,431 |
All Filings in LNSR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,107 | 857 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $11,222 | 965 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $12,942 | 1,048 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,802 | 1,048 | Shares | Defined | 2025-08-12 | |
| 2021-03-31 | $5,096 | 702 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,946 | 1,372 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||